Evidence map›Paper›PMID 35310838›Full record

ArticleFrontiers in cellular and infection microbiology2022

Nasal Bacterial Microbiome Differs Between Healthy Controls and Those With Asthma and Allergic Rhinitis.

Meiping Chen, Shiyi He, Phoebe Miles, Chunlin Li, Yijun Ge, Xuechan Yu, Linfeng Wang, Weina Huang, Xue Kong, Shanni Ma and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Microbiology spectrum · 2025
    Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Paradoxical enrichment ofFrontiers in immunology · 2026
    Article
  8. Nasal Microbiota Associated with the Lung Radiomic Features in Asthma.International journal of general medicine · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Immune Modulatory Role of Surfactants inJournal of inflammation research · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Meiping ChenSchool of Medicine, Ningbo University, Ningbo, China.
Shiyi HeSchool of Medicine, Ningbo University, Ningbo, China.
Phoebe MilesFaculty of Humanities and Social Sciences, University of Nottingham Ningbo, Ningbo, China.
Chunlin LiDepartment of Otorhinolaryngology-Head and Neck Surgery, Ningbo First Hospital, Ningbo, China.
Yijun GeSchool of Medicine, Ningbo University, Ningbo, China.
Xuechan YuSchool of Medicine, Ningbo University, Ningbo, China.
Linfeng WangDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Weina HuangDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Xue KongDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Shanni MaDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Yiting LiDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Qingwen JiangSchool of Medicine, Ningbo University, Ningbo, China.
Wen ZhangDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Chao CaoDepartment of Respiratory and Critical Care Medicine, Ningbo First Hospital, Ningbo, China.
Ningbo First Hospital · CNNingbo University · CNUniversity of Nottingham Ningbo China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perturbation of the microbiome has numerous associations with the phenotypes and progression in chronic airways disease. However, the differences in the nasal microbiome in asthma and allergic rhinitis (AR) have not been defined. We examined whether the nasal microbiome would vary among different comorbidities in asthma and AR and that those differences may be associated with the severity of asthma. Nasal lavage fluid was collected from 110 participants, including 20 healthy controls, 30 subjects with AR, 30 subjects with asthma and 30 subjects with combined asthma + AR. The Asthma Control Questionnaire (ACQ-7) was used to evaluate asthma control status. Using 16S rRNA bacterial gene sequencing, we analyzed nasal microbiome in patients with asthma, AR, combined asthma + AR, and healthy controls. Bacterial diversity was analyzed in corresponding with α diversity indices (Chao and Shannon index). Compared with healthy controls, the Chao index tended to be lower in subjects with AR (

Indexed as

AsthmaMicrobiotaRhinitis, AllergicBacteriaHumansRNA, Ribosomal, 16SRNA, Ribosomal, 16Sallergic rhinitisasthmadisease controlinflammationnasal microbiome

Identifiers

PMID35310838
PMCPMC8928226
OpenAlexW4214882022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.